MedPath

A Comparison Between Protemp and Flowable Light Cure Composite Material for Creating Optimal Gingival Emergence Profile Around Implant

Not Applicable
Completed
Conditions
Customized Healing Abutment
Dental Implant
Composite Resin
Peri-Implant Health
Registration Number
NCT07196293
Lead Sponsor
Amrita Institute of Medical Sciences & Research Center
Brief Summary

The study focuses on the critical role of the gingival emergence profile in the success of dental implants, emphasizing its importance for both peri-implant health and esthetics. The research aims to evaluate and compare the effectiveness of two common, cost-effective dental materials-light-cure composite and Protemp (a bis-acryl composite resin)-for fabricating customized healing abutments. By assessing the peri-implant tissue response to these materials, the study seeks to determine which is more suitable for creating an optimal, natural-looking soft tissue contour, thereby providing dentists with a practical and reliable alternative to more expensive options like PEEK.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
30
Inclusion Criteria
  • Age between 18 and 65 years.
  • Edentulous spaces to be replaced with implant-supported single crowns.
  • Antagonistic natural tooth present and sound (sound periodontium) (Stable occlusion and opposing dentition)
  • Good general periodontal health
  • Good general health.
  • Willing to participate in the study and able to sign informed consent. (Ability to attend all follow-up appointments.)
Exclusion Criteria
  • Untreated caries or periapical lesions in the opposing natural antagonistic tooth.
  • Active periodontal disease.
  • major active systemic disease affecting soft tissue healing
  • Multiple implant supported restorations already present.
  • Long edentulous spaces.
  • Complete edentulous cases

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Gingival Index (GI)T1: Immediately after the placement of the final prosthesis. T2: At the one-month follow-up appointment.

Gingival Index (GI): This index is used to evaluate inflammation of the gums around the implant.

Scale: 0 to 3.

Interpretation: A higher score indicates a worse outcome, signifying greater gingival inflammation.

Probing depth (PI)T1: Immediately after the placement of the final prosthesis. T2: At the one-month follow-up appointment.

Probing Depth (PD): This is a direct clinical measurement, not a scored scale, taken in millimeters at six points around the implant.

Interpretation: Deeper measurements are generally associated with less healthy peri-implant tissue. Therefore, a lower value indicates a better clinical outcome.

Pain Numeric ScaleT1: Immediately after the placement of the final prosthesis. T2: At the one-month follow-up appointment.

Pain Numeric Rating Scale (NRS): This scale measures the patient's subjective experience of pain during the insertion of the final prosthesis.

Scale: 0 ("no pain") to 10 ("worst pain imaginable").

Interpretation: A higher score indicates a worse outcome, representing more severe pain.

Pink Esthetic Score (PES)T1: Immediately after the placement of the final prosthesis. T2: At the one-month follow-up appointment.

Pink Esthetic Score (PES): This score is used to assess the aesthetic quality of the soft tissue surrounding the implant restoration.

Scale: 0 to 14.

Interpretation: A higher score indicates a better and more aesthetically pleasing outcome.

Secondary Outcome Measures
NameTimeMethod
Plaque Index (PI)T2: At the one-month follow-up appointment.

Plaque Index (PI): This index is used to quantify the amount of dental plaque present on the implant restoration.

Scale: 0 to 3.

Interpretation: A higher score indicates a worse outcome, corresponding to a greater accumulation of plaque.

Trial Locations

Locations (1)

Amrita School Of Dentistry

🇮🇳

Kochi, Kerala, India

Amrita School Of Dentistry
🇮🇳Kochi, Kerala, India

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.